Perceptive Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Perceptive Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-189,119	Closed	-$4.27M	–	146
2018 Q2	$4.27M	Sell	189,119 -56,693	-23%	-$1.34M	0.11%	76
2018 Q1	$7.13M	Sell	245,812 -50,000	-17%	-$1.46M	0.2%	71
2017 Q4	$8.25M	Sell	295,812 -45,700	-13%	-$1.42M	0.27%	58
2017 Q3	$12.6M	Sell	341,512 -259,554	-43%	-$8.03M	0.48%	49
2017 Q2	$13.3M	Buy	601,066 +90,185	+18%	+$710K	0.67%	42
2017 Q1	$3.01M	Buy	510,881 +200,000	+64%	+$1.44M	0.17%	75
2016 Q4	$1.68M	Hold	310,881	–	–	0.12%	86
2016 Q3	$2.77M	Hold	310,881	–	–	0.18%	79
2016 Q2	$2.99M	Buy	+310,881	New	+$3M	0.21%	74

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Perceptive Advisors's AVEO Position: Q3 2018 in Review

Perceptive Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2018, closing a stake of 189,119 shares — an estimated $4.27M sold.

Perceptive Advisors first reported a position in AVEO in Q2 2016 and held it in 9 quarters. The position peaked at $13.3M in Q2 2017. 101 funds tracked by Wall St. Rank hold AVEO as of Q3 2018.

Perceptive Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Perceptive Advisors sold 189,119 AVEO Pharmaceuticals, Inc. shares in Q3 2018, an estimated $4.27M.
Perceptive Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2016 and held it in 9 quarters.
Perceptive Advisors's AVEO Pharmaceuticals, Inc. position peaked at $13.3M in Q2 2017.
101 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2018.

Based on Perceptive Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.